Fifty-seven percent of healthcare organizations across 43 countries now rank AI as their top IT investment priority, according to KLAS…
Three healthcare leaders argue that hospital executives must take direct responsibility for AI oversight, not leave it to committees.
BMS is building dedicated AI compute infrastructure with Nvidia to accelerate molecular modeling and drug discovery.
Tempus AI adds Personalis' liquid biopsy and tumor sequencing capabilities in a $1.5 billion acquisition.
The Digital Medicine Society partners with the FDA and 30 organizations to build practical tools for hospital AI governance.
Advocate Health and ECU Health deployed AI agents on Epic's Agent Factory platform, cutting chart review time by 20 hours…
Health systems moving from pilot AI agents to production face twin challenges: maintaining clinical trust and managing the cost of…
MD Anderson researchers develop AI-guided technique to map brain tumor blood supply, enabling more precise delivery of targeted therapy.